Carmot Therapeutics Raises $150 Million in Series E Equity Financing to Advance its Pipeline of Treatments for Obesity and Diabetes Portfolio News / By Karina Tin May 25, 2023 Carmot Therapeutics Raises $150 Million in Series E Equity Financing to Advance its Pipeline of Treatments for Obesity and Diabetes Read More »
RAPT Therapeutics To Present Biomarker Data Corroborating Demonstrated Clinical Activity and Mechanism of Action of FLX475 in Advanced Cancers Portfolio News / By Karina Tin May 25, 2023 RAPT Therapeutics To Present Biomarker Data Corroborating Demonstrated Clinical Activity and Mechanism of Action of FLX475 in Advanced Cancers Read More »
eFFECTOR Therapeutics Reports Positive Data Updates from Phase 2 Expansion Cohorts Evaluating Zotatifin in Patients with ER+ Metastatic Breast Cancer at the ASCO 2023 Annual Meeting Portfolio News / By Karina Tin May 25, 2023 eFFECTOR Therapeutics Reports Positive Data Updates from Phase 2 Expansion Cohorts Evaluating Zotatifin in Patients with ER+ Metastatic Breast Cancer at the ASCO 2023 Annual Meeting Read More »
RAPT Therapeutics Reports First Quarter 2023 Financial Results Portfolio News / By Karina Tin May 11, 2023 RAPT Therapeutics Reports First Quarter 2023 Financial Results Read More »
Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update Portfolio News / By Karina Tin May 10, 2023 Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update Read More »
Surrozen Provides First Quarter 2023 Financial Results and Corporate and Pipeline Updates Portfolio News / By Karina Tin May 10, 2023 Surrozen Provides First Quarter 2023 Financial Results and Corporate and Pipeline Updates Read More »
Kallyope Receives $8.2 Million Grant to Identify Novel Interventions for Children and Undernourished Pregnant Women and Mothers Experiencing Environmental Enteric Dysfunction Portfolio News / By Karina Tin May 10, 2023 Kallyope Receives $8.2 Million Grant to Identify Novel Interventions for Children and Undernourished Pregnant Women and Mothers Experiencing Environmental Enteric Dysfunction Read More »
eFFECTOR Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update Portfolio News / By Karina Tin May 9, 2023 eFFECTOR Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update Read More »
NGM Bio Announces Presentation of Data from Phase 2 Investigator-Sponsored Trial of Aldafermin for the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) and Bile Acid Malabsorption (BAM) at Digestive Disease Week 2023 Portfolio News / By Karina Tin May 8, 2023 NGM Bio Announces Presentation of Data from Phase 2 Investigator-Sponsored Trial of Aldafermin for the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) and Bile Acid Malabsorption (BAM) at Digestive Disease Week 2023 Read More »
ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates Portfolio News / By Karina Tin May 8, 2023 ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates Read More »
